E H Ulm

2.7k total citations
47 papers, 1.6k citations indexed

About

E H Ulm is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, E H Ulm has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Genetics. Recurrent topics in E H Ulm's work include Protein Hydrolysis and Bioactive Peptides (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Estrogen and related hormone effects (8 papers). E H Ulm is often cited by papers focused on Protein Hydrolysis and Bioactive Peptides (9 papers), Retinoids in leukemia and cellular processes (8 papers) and Estrogen and related hormone effects (8 papers). E H Ulm collaborates with scholars based in United States. E H Ulm's co-authors include Daniel H. Rich, Eric T. Sun, Michael A. Shirley, Bruce I. LaMont, Joshua Boger, Martin Poe, Burton M. Pogell, Linda S. Payne, Terry W. Schorn and Edward H. Blaine and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

E H Ulm

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E H Ulm United States 23 1.1k 281 220 160 154 47 1.6k
Ishaiahu Shechter United States 30 1.6k 1.6× 121 0.4× 203 0.9× 155 1.0× 126 0.8× 66 3.0k
Brian R. Krause United States 33 1.3k 1.3× 236 0.8× 276 1.3× 133 0.8× 252 1.6× 94 3.1k
Paul Hadváry Switzerland 25 1.2k 1.1× 372 1.3× 246 1.1× 130 0.8× 232 1.5× 45 2.8k
Robert J. Ife United Kingdom 23 865 0.8× 417 1.5× 244 1.1× 83 0.5× 91 0.6× 52 1.7k
Mamoru Shoji United States 30 1.8k 1.7× 371 1.3× 493 2.2× 52 0.3× 100 0.6× 63 3.0k
Shin‐Hun Juang Taiwan 25 814 0.8× 360 1.3× 327 1.5× 81 0.5× 43 0.3× 69 2.0k
Ruth I. Geran United States 9 624 0.6× 225 0.8× 318 1.4× 80 0.5× 39 0.3× 12 1.3k
Ladislav Mirossay Slovakia 22 877 0.8× 326 1.2× 375 1.7× 54 0.3× 33 0.2× 79 2.0k
Raymond E. Counsell United States 23 743 0.7× 354 1.3× 152 0.7× 43 0.3× 57 0.4× 163 2.4k
Drago R. Sliskovic United States 19 617 0.6× 468 1.7× 205 0.9× 124 0.8× 208 1.4× 46 1.6k

Countries citing papers authored by E H Ulm

Since Specialization
Citations

This map shows the geographic impact of E H Ulm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E H Ulm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E H Ulm more than expected).

Fields of papers citing papers by E H Ulm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E H Ulm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E H Ulm. The network helps show where E H Ulm may publish in the future.

Co-authorship network of co-authors of E H Ulm

This figure shows the co-authorship network connecting the top 25 collaborators of E H Ulm. A scholar is included among the top collaborators of E H Ulm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E H Ulm. E H Ulm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizvi, Naiyer A., J L Marshall, Elizabeth Ness, et al.. (1998). Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.. PubMed. 4(6). 1437–42. 23 indexed citations
2.
Shirley, Michael A., Youssef L. Bennani, Marcus F. Boehm, et al.. (1996). Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.. Drug Metabolism and Disposition. 24(3). 293–302. 27 indexed citations
3.
Adamson, Peter C., et al.. (1995). Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.. PubMed. 55(3). 482–5. 15 indexed citations
4.
Halpin, Rita A., E H Ulm, A. E. Till, et al.. (1993). Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.. Drug Metabolism and Disposition. 21(6). 1003–1011. 47 indexed citations
5.
6.
Lin, Jiunn H., et al.. (1990). Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in rabbits following single and multiple doses.. Drug Metabolism and Disposition. 18(6). 836–841. 4 indexed citations
7.
Lin, J H, F A deLuna, E H Ulm, & Dominick J. Tocco. (1990). Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.. Drug Metabolism and Disposition. 18(4). 484–487. 14 indexed citations
8.
Lin, Jiunn H., F A deLuna, Dominick J. Tocco, & E H Ulm. (1989). Effect of experimental diabetes on elimination kinetics of diflunisal in rats.. Drug Metabolism and Disposition. 17(2). 147–152. 10 indexed citations
9.
Lin, Jiunn H., et al.. (1989). Dose-dependent kinetics of cilastatin in laboratory animals.. Drug Metabolism and Disposition. 17(4). 426–432. 5 indexed citations
10.
Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1987). Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini. Journal of Medicinal Chemistry. 30(10). 1853–1857. 9 indexed citations
11.
Lin, J H, et al.. (1987). Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1013–1018. 11 indexed citations
12.
Thorsett, Eugene D., Elbert E. Harris, Susan D. Aster, et al.. (1986). ChemInform Abstract: Conformationally Restricted Inhibitors of Angiotensin Converting Enzyme: Synthesis and Computations.. Chemischer Informationsdienst. 17(23). 9 indexed citations
13.
Boger, Joshua, Linda S. Payne, Debra S. Perlow, et al.. (1985). Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analog inhibitors containing a novel analog of statine. Journal of Medicinal Chemistry. 28(12). 1779–1790. 111 indexed citations
14.
Veber, Daniel F., Mark G. Bock, Stephen F. Brady, et al.. (1984). Renin inhibitors containing 2-substituted statine. Biochemical Society Transactions. 12(6). 956–959. 7 indexed citations
15.
Pang, K. Sandy, W F Cherry, Julia A. Terrell, & E H Ulm. (1984). Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.. Drug Metabolism and Disposition. 12(3). 309–313. 41 indexed citations
16.
Parsons, William H., D. Taub, Susan D. Aster, et al.. (1983). Benzolactams. A new class of converting enzyme inhibitors. Biochemical and Biophysical Research Communications. 117(1). 108–113. 17 indexed citations
17.
Rich, Daniel H., Eric T. Sun, & E H Ulm. (1980). Synthesis of analogs of the carboxyl protease inhibitor pepstatin. Effect of structure on inhibition of pepsin and renin. Journal of Medicinal Chemistry. 23(1). 27–33. 119 indexed citations
18.
Ludden, Carl T., Alexander Scriabine, E H Ulm, et al.. (1979). Antihypertensive activity of some novel pyridinylidene arylurea derivatives in spontaneously hypertensive rats. Cellular and Molecular Life Sciences. 35(6). 799–801. 2 indexed citations
19.
Scriabine, Alexander, Carl T. Ludden, Charles S. Sweet, et al.. (1978). Antihypertensive Activity of Metyrosine in Spontaneously Hypertensive Rats and its Enhancement by Carbidopa. Clinical Science. 55(s4). 255s–257s. 3 indexed citations
20.
Ham, Edward A., et al.. (1975). The reaction of PGA1 with sulfhydryl groups; a component in the binding of A-type prostaglandins to proteins. Prostaglandins. 10(4). 217–229. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ishaiahu Shechter Breakdown of academic impact, for papers by Brian R. Krause Breakdown of academic impact, for papers by Paul Hadváry Breakdown of academic impact, for papers by Robert J. Ife Breakdown of academic impact, for papers by Mamoru Shoji Breakdown of academic impact, for papers by Shin‐Hun Juang Breakdown of academic impact, for papers by Ruth I. Geran Breakdown of academic impact, for papers by Ladislav Mirossay Breakdown of academic impact, for papers by Raymond E. Counsell Breakdown of academic impact, for papers by Drago R. Sliskovic
Rankless by CCL
2026